Attached files
| file | filename |
|---|---|
| EX-10.12 - EX-10.12 - CONCERT PHARMACEUTICALS, INC. | q420exhibit1012.htm |
| EX-32.2 - EX-32.2 - CONCERT PHARMACEUTICALS, INC. | q420exhibit322.htm |
| EX-32.1 - EX-32.1 - CONCERT PHARMACEUTICALS, INC. | q420exhibit321.htm |
| EX-31.2 - EX-31.2 - CONCERT PHARMACEUTICALS, INC. | q420exhibit312.htm |
| EX-31.1 - EX-31.1 - CONCERT PHARMACEUTICALS, INC. | q420exhibit311.htm |
| EX-21.1 - EX-21.1 - CONCERT PHARMACEUTICALS, INC. | q420exhibit211.htm |
| 10-K - 10-K - CONCERT PHARMACEUTICALS, INC. | cnce-20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-223334) of Concert Pharmaceuticals, Inc. and the related Prospectus;
(2)Registration Statement (Form S-3 No. 333-249862) of Concert Pharmaceuticals, Inc. and the related Prospectus;
(3)Registration Statement (Form S-8 No. 333-195125) pertaining to the Amended and Restated 2006 Stock Option and Grant Plan and 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
(4)Registration Statement (Form S-8 No. 333-202453) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
(5)Registration Statement (Form S-8 No. 333-209841) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
(6)Registration Statement (Form S-8 No. 333-216459) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
(7)Registration Statement (Form S-8 No. 333-223335) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
(8)Registration Statement (Form S-8 No. 333-229932) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.; and
(9)Registration Statement (Form S-8 No. 333-236679) pertaining to the 2014 Stock Incentive Plan of Concert Pharmaceuticals, Inc.;
of our report dated February 25, 2021, with respect to the consolidated financial statements of Concert Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Concert Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 25, 2021